Related Experiment Video
Updated: Jun 6, 2025
09:17
Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
21.6K
[Relationship Between Dementia and Lifestyle Diseases]
Ryosuke Shimasaki1, Masanori Kurihara, Atsushi Iwata
1Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology.
No Shinkei Geka. Neurological Surgery
|December 2, 2024
Summary
Preventing dementia is crucial as populations age. Comprehensive management of lifestyle diseases like hypertension and diabetes in middle age, rather than individual treatments, shows promise in reducing dementia incidence.
Area of Science:
- Gerontology and Public Health
- Neuroscience and Neurology
- Cardiovascular and Metabolic Diseases
Background:
- Global dementia incidence is rising with aging populations, highlighting the need for effective prevention strategies.
- Lifestyle diseases, including hypertension, diabetes, and dyslipidemia, are significantly linked to dementia development.
- Early intervention and control of these conditions in middle-aged individuals are critical for dementia prevention.
Purpose of the Study:
- To review the association between lifestyle diseases and dementia.
- To evaluate the potential of pharmacological interventions for lifestyle diseases in reducing dementia incidence.
- To emphasize the importance of comprehensive management strategies for lifestyle diseases in dementia prevention.
Main Methods:
- Literature review on the relationship between hypertension, diabetes, dyslipidemia, and dementia.
- Analysis of drug classes (e.g., antihypertensives, hypoglycemics, statins) and their potential impact on dementia.
- Discussion of the efficacy of individual versus comprehensive lifestyle disease management.
Main Results:
- Hypertension shows a strong association with dementia, necessitating strict blood pressure control.
- Certain medications for hypertension, diabetes (GLP-1 RAs, SGLT-2 inhibitors), and dyslipidemia (statins) may lower dementia risk.
- Individual lifestyle disease interventions offer limited dementia prevention benefits; comprehensive approaches are more effective.
Conclusions:
- Clinicians must possess robust knowledge of lifestyle diseases for effective management.
- Early and comprehensive management of lifestyle diseases is essential for mitigating dementia risk.
- Integrated strategies targeting multiple lifestyle diseases are key to significantly reducing dementia incidence.
Related Concept Videos
01:30Dementia
96
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
96
01:20Lifestyle Factors and Health
34
Lifestyle factors play a critical role in maintaining overall health and preventing chronic diseases. Key elements, such as regular physical activity, a nutritious diet, and abstinence from smoking, can significantly enhance physical, mental, and emotional well-being while reducing the risk of several life-threatening conditions.
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
34
01:26Alzheimer's Disease: Overview
447
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
447
01:19Psychoneuroimmunology: Diabetes and Cancer
24
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
24
01:26Stress Prevention and Stress Management Techniques IV
26
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
26
01:22Alzheimer's Disease: Treatment
163
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
163